Viewing Opinion | StockChase
Abbott Labs (ABT-N) opinion on 2012-10-11

Last Price Recorded: 55.2900 on 2017-11-20

ON STOCKCHASE SINCE Jan 2001

biotechnology/pharmaceutical
TOP PICK

David Burrows
Abbott Labs was $69.420 at time of opinion
Owned : Yes

2.9% dividend. Going down the path into splitting into two businesses. The pharma business has a higher than industry growth rate. Best performing sector in the market at present. The patent cliff is here and priced into the stock price.


SELECTIVE

All opinions for ABT-N (106)

30 BUY
5 BUY on WEAKNESS
17 COMMENT
7 DON'T BUY
6 HOLD
14 PAST TOP PICK
1 SELL
1 SELL ON STRENGTH
23 TOP PICK
2 WAIT
View All

More experts covering ABT-N

SAVE
Add ABT-N to Watch List

All opinions for ABT-N (106)

30 BUY
5 BUY on WEAKNESS
17 COMMENT
7 DON'T BUY
6 HOLD
14 PAST TOP PICK
1 SELL
1 SELL ON STRENGTH
23 TOP PICK
2 WAIT
View All

More experts covering ABT-N

SAVE
Add ABT-N to Watch List

No Comments.


You must be logged in to comment.

Successfully Saved Company